Persistent lung inflammation and fibrosis in serum amyloid P component (Apcs-/-) knockout mice

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Pilling, Darrell ^a   Gomer, Richard H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; BLEOMYCIN; PENTRAXIN; SERUM AMYLOID P;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HEART MUSCLE FIBROSIS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; MACROPHAGE; MOUSE; MYELOFIBROSIS; NONHUMAN; PNEUMONIA; PROTEIN BLOOD LEVEL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; GENETICS; KNOCKOUT MOUSE; LUNG; PATHOLOGY;

ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; PULMONARY FIBROSIS; SERUM AMYLOID P-COMPONENT;

EID: 84898798223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093730     Document Type: Article

References (95)

1. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine 18: 1028-1040.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. American Journal of Respiratory and Critical Care Medicine 183: 788-824.
3. Gomer RH (2013) New Approaches to Modulating Idiopathic Pulmonary Fibrosis. Current Allergy and Asthma Reports: 1-6.
4. Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2013) Host Responses in Tissue Repair and Fibrosis. Annual Review of Pathology: Mechanisms of Disease 8: 241-276.
5. Reilkoff RA, Bucala R, Herzog EL (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 11: 427-435.
6. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686. (Pubitemid 39457982)
7. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
8. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
9. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature immunology 11: 889-896.
10. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine 1: 71-81.
11. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology 166: 7556-7562. (Pubitemid 32525636)
12. Pilling D, Buckley CD, Salmon M, Gomer RH (2003) Inhibition of fibrocyte differentiation by serum amyloid P. Journal Of Immunology 17: 5537-5546. (Pubitemid 37432844)
13. Pilling D, Tucker NM, Gomer RH (2006) Aggregated IgG inhibits the differentiation of human fibrocytes. Journal Of Leukocyte Biology 79: 1242-1251. (Pubitemid 44835558)
14. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of Leukocyte Biology 83: 1323-1333. (Pubitemid 351960310)
15. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S (2003) Identification of Circulating Fibrocytes as Precursors of Bronchial Myofibroblasts in Asthma. The Journal of Immunology 171: 380-389. (Pubitemid 36745311)
16. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, et al. (2007) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353: 104-108. (Pubitemid 44958347)
17. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. The International Journal of Biochemistry & Cell Biology 36: 598-606. (Pubitemid 38316817)
18. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. Journal Of Clinical Investigation 113: 243-252. (Pubitemid 38544209)
19. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J ClinInvest 114: 438-446. (Pubitemid 39071616)
20. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, et al. (2006) The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis. American Journal Of Respiratory Cell And Molecular Biology 35: 175-181. (Pubitemid 44175316)
21. Crawford JR, Pilling D, Gomer RH (2012) FccRI mediates serum amyloid P inhibition of fibrocyte differentiation. Journal of Leukocyte Biology 92: 699-711.
22. Crawford JR, Pilling D, Gomer RH (2010) Improved serum-free culture conditions for spleen-derived murine fibrocytes. Journal Of Immunological Methods 363: 9-20.
23. Naik-Mathuria B, Pilling D, Crawford JR, Gay AN, Smith CW, et al. (2008) Serum amyloid P inhibits dermal wound healing. Wound Repair and Regeneration 16: 266-273. (Pubitemid 351342135)
24. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, et al. (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. The Journal of Immunology 179: 4035-4044.
25. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, et al. (2006) Bone Marrow-derived Fibroblast Precursors Mediate Ischemic Cardiomyopathy in Mice. Proceedings of the National Academy of Sciences 103: 18284-18289. (Pubitemid 44871650)
26. Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. ImmunolToday 15: 81-88. (Pubitemid 24049801)
27. Pepys MB, Baltz M, Gomer K, Davies AJ, Doenhoff M (1979) Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278: 259-261. (Pubitemid 9129075)
28. Le PT, Muller MT, Mortensen RF (1982) Acute phase reactants of mice. I. Isolation of serum amyloid P- component (SAP) and its induction by a monokine. JImmunol 129: 665-672. (Pubitemid 12039393)
29. Haudek SB, Trial J, Xia Y, Gupta D, Pilling D, et al. (2008) Fc Receptor Engagement Mediates Differentiation of Cardiac Fibroblast Precursor Cells. Proceedings of the National Academy of Sciences 105: 10179-10184
30. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS, et al. (2010) Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages. PLoS ONE 5: e9683.
31. Murray L, Kramer M, Hesson D, Watkins B, Fey E, et al. (2010) Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis & Tissue Repair 3: 11.
32. Murray LA, Chen Q, Kramer MS, Hesson DP, Argentieri RL, et al. (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 43: 154-162.
33. Castano AP, Lin SL, Surowy T, Nowlin BT, Turlapati SA, et al. (2009) Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Science translational medicine 1: 5ra13.
34. Moreira AP, Cavassani KA, Hullinger R, Rosada RS, Fong DJ, et al. (2010) Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol 126: 712-721 e717.
35. Pilling D, Fan T, Huang D, Kaul B, Gomer RH (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4: e7475.
36. Ji Z, Ke ZJ, Geng JG (2011) SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol Cell Biol 90: 388-395.
37. Dillingh MR, van den Blink B, Moerland M, van Dongen MGJ, Levi M, et al. (2013) Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 26: 672-676
38. Bharadwaj D, Mold C, Markham E, Du Clos TW (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. JImmunol 166: 6735-6741. (Pubitemid 32467217)
39. Grage-Griebenow E, Flad HD, Ernst M (2001) Heterogeneity of human peripheral blood monocyte subsets. JLeukocBiol 69: 11-20. (Pubitemid 32095112)
40. Chi M, Tridandapani S, Zhong W, Coggeshall KM, Mortensen RF (2002) C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes. JImmunol 168: 1413-1418. (Pubitemid 34094513)
41. Mold C, Baca R, Du Clos TW (2002) Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. Journal of autoimmunity 19: 147-154. (Pubitemid 35341864)
42. Macdonald SL, Kilpatrick DC (2006) Human serum amyloid P component binds to peripheral blood monocytes. Scand J Immunol 64: 48-52.
43. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
44. Biburger M, Aschermann S, Schwab I, Lux A, Albert H, et al. (2011) Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo. Immunity 35: 932-944.
45. Ravetch JV, Kinet JP (1991) Fc receptors. AnnuRevImmunol 9: 457-492.
46. Pilling D, Vakil V, Gomer RH (2009) Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. Journal of Immunological Methods 351: 62-70.
47. Cox N, Pilling D, Gomer RH (2012) NaCl Potentiates Human Fibrocyte Differentiation. PLoS One 7: e45674.
48. Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, et al. (1997) Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. NatMed 3: 855-859. (Pubitemid 27353444)
49. Togashi S, Lim SK, Kawano H, Ito S, Ishihara T, et al. (1997) Serum amyloid P component enhances induction of murine amyloidosis. Lab Invest 77: 525-531. (Pubitemid 27508623)
50. Soma M, Tamaoki T, Kawano H, Ito S, Sakamoto M, et al. (2001) Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease. BiochemBiophysResCommun 286: 200-205. (Pubitemid 32917670)
51. Yuste J, Botto M, Bottoms SE, Brown JS (2007) Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog 3: 1208-1219. (Pubitemid 47510274)
52. Walters DM, Kleeberger SR (2008) Mouse Models of Bleomycin-Induced Pulmonary Fibrosis: John Wiley & Sons, Inc.
53. Maharjan AS, Roife D, Brazill D, Gomer RH (2013) Serum amyloid P inhibits granulocyte adhesion. Fibrogenesis Tissue Repair 6: 2.
54. Herlihy SE, Pilling D, Maharjan AS, Gomer RH (2013) Dipeptidyl Peptidase IV Is a Human and Murine Neutrophil Chemorepellent. The Journal of Immunology 190: 6468-6477.
55. Kebaier C, Chamberland RR, Allen IC, Gao X, Broglie PM, et al. (2012) Staphylococcus aureus a-Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome. Journal of Infectious Diseases 205: 807-817.
56. Daubeuf F, Frossard N (2012) Performing Bronchoalveolar Lavage in the Mouse. Current Protocols in Mouse Biology: John Wiley & Sons, Inc. pp. 167-175.
57. Pilling D, Akbar AN, Girdlestone J, Orteu CH, Borthwick NJ, et al. (1999) Interferon-b mediates stromal cell rescue of T cells from apoptosis. European Journal Of Immunology 29: 1041-1050. (Pubitemid 29119085)
58. Haston CK, Amos CI, King TM, Travis EL (1996) Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res 56: 2596-2601. (Pubitemid 26170697)
59. Kumar RK (2005) Morphological methods for assessment of fibrosis. Methods MolMed 117: 179-188.
60. Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, et al. (2008) Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44: 507-511, 514-507.
61. Ding J, Yannam GR, Roy-Chowdhury N, Hidvegi T, Basma H, et al. (2011) Spontaneous hepatic repopulation in transgenic mice expressing mutant human a1- antitrypsin by wild-type donor hepatocytes. The Journal of Clinical Investigation 121: 1930-1934.
62. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332. (Pubitemid 350073596)
63. Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, et al. (2011) Quantitative assessment of macrophage functions in repair and fibrosis. Current protocols in immunology/edited by John E Coligan [et al] Chapter 14: Unit 14 22.
64. Gomer RH, Pilling D, Kauvar L, Ellsworth S., Pissani S, et al. (2009) A Serum Amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair and Regeneration 17: 397-404.
65. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, et al. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. NatMed 5: 694-697. (Pubitemid 29289434)
66. Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, et al. (2004) Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoSBiol 2: E243.
67. Heidari Y, Bygrave AE, Rigby RJ, Rose KL, Walport MJ, et al. (2006) Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun 7: 592-599. (Pubitemid 44614874)
68. Carlucci F, Cortes-Hernandez J, Fossati-Jimack L, Bygrave AE, Walport MJ, et al. (2007) Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol 178: 2352-2360. (Pubitemid 46233434)
69. Van Molle W, Hochepied T, Brouckaert P, Libert C (2000) The Major Acute-Phase Protein, Serum Amyloid P Component, in Mice Is Not Involved in Endogenous Resistance against Tumor Necrosis Factor Alpha-Induced Lethal Hepatitis, Shock, and Skin Necrosis. Infection and Immunity 68: 5026-5029.
70. Kumar V, Abbas AK, Fausto N, Kumar V, Abbas AK, et al. (2005) Acute and Chronic Inflammation. Robbins and Cotran: Pathological Basis of Disease. Philadelphia: Elsevier Saunders. pp. 47-86.
71. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, et al. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325: 612-616.
72. Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, et al. (2009) CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 106: 17892-17897.
73. Rose S, Misharin A, Perlman H (2012) A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry Part A 81A: 343-350.
74. Unkeless JC (1979) Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. The Journal of Experimental Medicine 150: 580-596.
75. Keller R, Keist R, Bazin H, Joller P, van Der Meide PH (1990) Binding of monomeric immunoglobulins by bone marrow-derived mononuclear phagocytes; its modulation by interferon- c. European Journal of Immunology 20: 2137-2140. (Pubitemid 20355641)
76. Moore BB, Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-160. (Pubitemid 351253350)
77. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M (2008) The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? The International Journal of Biochemistry & Cell Biology 40: 362-382. (Pubitemid 351249887)
78. Wang D, Morales JE, Calame DG, Alcorn JL, Wetsel RA (2010) Transplantation of Human Embryonic Stem Cell-Derived Alveolar Epithelial Type II Cells Abrogates Acute Lung Injury in Mice. Mol Ther 18: 625-634.
79. Mouratis MA, Aidinis V (2011) Modeling pulmonary fibrosis with bleomycin. Current opinion in pulmonary medicine 17: 355-361.
80. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, et al. (2012) Distinct Macrophage Subpopulations Characterize Acute Infection and Chronic Inflammatory Lung Disease. The Journal of Immunology 189: 946-955.
81. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, et al. (2011) Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. Am J Respir Crit Care Med 184: 569-581.
82. Yona S, Kim K-W, Wolf Y, Mildner A, Varol D, et al. (2013) Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis. Immunity 38: 79-91.
83. Johnston LK, Rims CR, Gill SE, McGuire JK, Manicone AM (2012) Pulmonary Macrophage Subpopulations in the Induction and Resolution of Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology 47: 417-426.
84. Duffield JS, Lupher ML Jr. (2010) PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News Perspect 23: 305-315.
85. Pepys MB, Baltz ML, Musallam R, Doenhoff MJ (1980) Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP). Immunology 39: 249-254. (Pubitemid 10118134)
86. Mortensen RF, Beisel K, Zeleznik NJ, Le PT (1983) Acute-phase reactants of mice. II. Strain dependence of serum amyloid P- component (SAP) levels and response to inflammation. JImmunol 130: 885-889. (Pubitemid 13186323)
87. Parker JC, Townsley MI (2004) Evaluation of lung injury in rats and mice. American Journal of Physiology - Lung Cellular and Molecular Physiology 286: L231-L246. (Pubitemid 38129502)
88. Kulkarni AA, Thatcher TH, Hsiao H-M, Olsen KC, Kottmann RM, et al. (2013) The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis. PLoS ONE 8: e63798.
89. Schrier DJ, Kunkel RG, Phan SH (1983) The role of strain variation in murine bleomycin-induced pulmonary fibrosis. AmRevRespirDis 127: 63-66. (Pubitemid 13168313)
90. Chung MP, Monick MM, Hamzeh NY, Butler NS, Powers LS, et al. (2003) Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J RespirCell MolBiol 29: 375-380. (Pubitemid 37093996)
91. Haston CK, Wang M, Dejournett RE, Zhou X, Ni D, et al. (2002) Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. HumMolGenet 11: 1855-1863.
92. Lu J, Marjon KD, Mold C, Du Clos TW, Sun PD (2012) Pentraxins and Fc receptors. Immunological Reviews 250: 230-238.
93. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. NatRevImmunol 2: 965-975. (Pubitemid 37323217)
94. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, et al. (2008) Structural recognition and functional activation of FcgR by innate pentraxins. Nature 456: 989-992.
95. Zhang W, Xu W, Xiong S (2011) Macrophage Differentiation and Polarization via Phosphatidylinositol 3-Kinase/Akt-ERK Signaling Pathway Conferred by Serum Amyloid P Component. The Journal of Immunology 187: 1764-1777.